Provided by Tiger Trade Technology Pte. Ltd.

Amphastar Pharmaceuticals

26.07
+0.46001.80%
Post-market: 26.070.00000.00%17:49 EST
Volume:389.78K
Turnover:10.18M
Market Cap:1.20B
PE:11.49
High:26.52
Open:25.60
Low:25.47
Close:25.61
52wk High:41.84
52wk Low:20.39
Shares:45.95M
Float Shares:34.80M
Volume Ratio:0.94
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.27
EPS(LYR):3.29
ROE:14.84%
ROA:6.74%
PB:1.54
PE(LYR):7.91

Loading ...

Amphastar Pharma Q3 Adj. EPS $0.93 Beats $0.85 Estimate, Sales $191.840M Beat $184.728M Estimate

Benzinga
·
Nov 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 06

Amphastar Director Floyd F. Petersen Reports Sale of Common Shares

Reuters
·
Nov 06

Should Amphastar’s (AMPH) Exclusive 10-Year BAQSIMI Deal in Greater China Prompt Investor Action?

Simply Wall St.
·
Oct 26

Amphastar Pharmaceuticals Inc - on Oct 21, Co's Unit and Chengong Enter Distribution Agreement - SEC Filing

THOMSON REUTERS
·
Oct 25

Amphastar Pharmaceuticals Inc - Chengong Appointed Exclusive Distributor for Baqsimi in Greater China - SEC Filing

THOMSON REUTERS
·
Oct 25

Amphastar Pharmaceuticals Inc - Agreement Term Is 10 Years With Extension Negotiations Possible - SEC Filing

THOMSON REUTERS
·
Oct 25

Amphastar Pharmaceuticals Appoints Chengong as Exclusive Distributor for BAQSIMI in Greater China

Reuters
·
Oct 25

Amphastar Pharmaceuticals: Strategic Shift and Growth Catalysts Justify Buy Rating with $36 Target

TIPRANKS
·
Oct 22

Can Amphastar Pharmaceuticals (AMPH) Navigate Heightened Trade Tensions to Protect Its Supply Chain Advantage?

Simply Wall St.
·
Oct 13

Ionis, Jazz Named Top Picks as US Biopharma Heads Into Steady Q3, BofA Says

MT Newswires Live
·
Oct 09

BofA Cuts Price Target on Amphastar Pharmaceuticals to $31 From $32

MT Newswires Live
·
Oct 09

Amphastar price target lowered to $31 from $32 at BofA

TIPRANKS
·
Oct 09

Amphastar Pharmaceuticals Director Floyd F. Petersen Reports Sale of Common Shares

Reuters
·
Oct 03

Amphastar Pharmaceuticals Inc - on Sept 15, Enters Contract Research Agreement With Hanxin - SEC Filing

THOMSON REUTERS
·
Sep 19

Is Weakness In Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Simply Wall St.
·
Sep 19

Director Floyd F. Petersen Reports Disposal of Common Shares in Amphastar Pharmaceuticals Inc

Reuters
·
Sep 04

Amphastar Pharmaceuticals to Participate in Analyst-Moderated Fireside Chat at Wells Fargo Healthcare Conference

Reuters
·
Aug 28

Amphastar Pharmaceuticals Is Maintained at Neutral by B of A Securities

Dow Jones
·
Aug 26

Amphastar Pharmaceuticals Inc : Bofa Global Research Raises Price Objective to $32 From $28

THOMSON REUTERS
·
Aug 26